Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06893302 · ClinicalTrials.gov registry record · NA
Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy
A NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06893302 is a NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 50 participants, below the 1,407-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06893302, a NA study of Osteoarthritis (OA) of the Knee and Cartilage Defects of the Knee, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether using bone marrow aspirate (BMA) during knee arthroscopy surgery can improve patient outcomes. The investigators will enroll 50 patients who need knee arthroscopy surgery for meniscus injuries or cartilage damage. Like flipping a coin, patients will be randomly assigned to one of two groups of 25 patients each. One group will receive standard arthroscopic surgery plus an injection of bone marrow aspirate, while the other group will receive standard surgery plus a saline (salt water) injection. During surgery, for patients in the treatment group, approximately 4mL (less than one teaspoon) of bone marrow will be taken from their hip bone using a special needle system. A small amount (1mL) will be sent to the laboratory for testing. Patients will be followed for 12 months after surgery and will complete questionnaires about their pain levels and knee function at several time points: before surgery, 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after surgery. These questionnaires will ask about pain, daily activities, and overall improvement.
Conditions Studied
Interventions
- OTHER Saline
- BIOLOGICAL Bone Marrow Aspirate (BMA)
- PROCEDURE Arthroscopic Debridement Surgery
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06 |
| Est. Completion | 2029-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06893302
The ClinicalTrials.gov registry entry for NCT06893302 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,407-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (96% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Osteoarthritis (OA) of the Knee appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.
NCT06893302 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06893302 about?
NCT06893302 is a clinical study titled "Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy". This study will examine whether using bone marrow aspirate (BMA) during knee arthroscopy surgery can improve patient outcomes. The investigators will enroll 50 patients who need knee arthroscopy surgery for meniscus injuries or cartilage damage. Like flipping a coin, patients will be randomly assign...
What is the current status of trial NCT06893302?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06. Estimated completion is 2029-04.
What conditions does trial NCT06893302 study?
This clinical trial studies the following conditions: Osteoarthritis (OA) of the Knee, Cartilage Defects of the Knee, Chondral Lesion of the Knee, Meniscal Injuries.
What interventions are being tested in trial NCT06893302?
The interventions under investigation include: Saline (OTHER), Bone Marrow Aspirate (BMA) (BIOLOGICAL), Arthroscopic Debridement Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06893302?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06893302 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis (OA) of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Platelet Rich Plasma for Musculoskeletal Conditions
RECRUITING · NA
-
Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty
RECRUITING · NA
-
Injectable Cold Energy Therapy FOR THE Management OF Chronic Pain Associated With Osteoarthritis OF THE Knee
ACTIVE NOT RECRUITING · NA
-
Photographic Evidence on Total Knee Arthroplasty Outcomes
COMPLETED · NA
-
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
RECRUITING · Phase 4
Explore more on PlainTrial
Osteoarthritis (OA) of the Knee
All registered trials for this condition
Cartilage Defects of the Knee
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.